Results 10,061-10,080 of 34,616 for speaker:Seán Fleming
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Will Ms Jackson make a note to send it to the committee for its consideration? It is an issue that we can come back to. I do not know whose time I am after eating into there. The next speaker is Deputy Connolly.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Deputy Kelly is next, followed by Deputy Aylward, Deputy Cullinane and Deputy MacSharry. I will call on them in sequence. Deputy Aylward has not spoken at all yet.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Mr. McCallion referred to a steering group. Is there an implementation committee too? Is there more than one group overseeing this?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Is that is chaired by the deputy director of operations?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: What grade is that person?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: How much of the implementation will not be within the remit of the HSE?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: So, one third will be external, in the Department. Mr. McCallion has said there will be a steering committee and an implementation committee in the HSE-----
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: There will be another implementation committee in the Department of Health. I am interested in the third at the Department of Health.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Is there a figure?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: One would get the impression from the Department's formal response that there is no figure and that a decision was made to just go ahead and do it. I am not saying that there was not a need to deal with the issue but-----
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Ms Jackson.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: That is €10 million.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Women are continuing to-----
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: We need more information.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Yes.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Have the 30 people travelled to have the test carried out?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: How many people who went to the Irish Thalidomide Medical Assessment Board that felt they had a case and were not accepted when they travelled to Sweden? How many did not come through the medical assessment as defined by-----
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Therefore, two thirds of them did not. How many of them travelled to Sweden in more recent years to undertake the international assessment?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Only six of the other 60 travelled?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: This is probably a medical issue. A total of 66 people who went to the Irish Thalidomide Medical Assessment Board must have felt they had a case, but their injuries were not defined as such. What injuries did they think were thalidomide-related but the board stated "No"?